LOGIN  |  REGISTER
Surmodics

ICU Medical (NASDAQ: ICUI) Stock Quote

Last Trade: US$97.10 -1.10 -1.12
Volume: 204,254
5-Day Change: -4.51%
YTD Change: -2.65%
Market Cap: US$2.370B

Latest News From ICU Medical

SAN CLEMENTE, Calif., March 13, 2024 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the KeyBanc Life Sciences & MedTech Investor Forum being held virtually March 19-20, 2024. ICU Medical’s presentation will be on Wednesday, March 20, 2024 at 11:15 a.m. PT (2:15 p.m. ET). Company management... Read More
SAN CLEMENTE, Calif., March 01, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the Raymond James 45 th Annual Institutional Investors Conference being held in Orlando, Florida, March 3-6, 2024. ICU Medical’s presentation will be on Monday, March 4, 2024 at 4:30 a.m. PT (7:30... Read More
SAN CLEMENTE, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarter ended December 31, 2023. Fourth Quarter 2023 Results Fourth quarter 2023 revenue was $587.9 million, compared to $578.0 million in the same period in the prior year. GAAP gross profit for the fourth quarter... Read More
SAN CLEMENTE, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its fourth quarter 2023 earnings release and conference call. The Company will release its fourth quarter 2023 results on Tuesday, February 27 th , 2024 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a... Read More
SAN CLEMENTE, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarter ended September 30, 2023. Third Quarter 2023 Results Third quarter 2023 revenue was $553.3 million, compared to $597.9 million in the same period last year. GAAP gross profit for the third quarter of 2023... Read More
SAN CLEMENTE, Calif., Oct. 23, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its third quarter 2023 earnings release and conference call. The Company will release its third quarter 2023 results on Monday, November 6 th , 2023 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference... Read More
SAN CLEMENTE, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will participate in a fireside chat at the Morgan Stanley Annual Global Healthcare Conference at 4:30 a.m. PT (7:30 a.m. ET) on Tuesday, September 12, 2023. Company management will also be participating in one-on-one... Read More
HealthStocksHub
The clinician-driven design of the precision system is the foundation of ICU Medical's long-term IV systems product road map that seeks to blend ease of use with proven medication delivery and safety SAN CLEMENTE , Calif. , Aug. 29, 2023 /PRNewswire/ -- ICU Medical Inc. , a worldwide leader in the development, manufacture and... Read More
SAN CLEMENTE, Calif., Aug. 07, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarter ended June 30, 2023. Second Quarter 2023 Results Second quarter 2023 revenue was $549.3 million, compared to $561.0 million in the same period last year. GAAP gross profit for the second quarter of 2023 was... Read More
SAN CLEMENTE, Calif., July 24, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter 2023 earnings release and conference call. The Company will release its second quarter 2023 results on Monday, August 7 th , 2023 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference... Read More
SAN CLEMENTE, Calif., May 08, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarter ended March 31, 2023. First Quarter 2023 Results First quarter 2023 revenue was $568.6 million, compared to $543.1 million in the same period last year. GAAP gross profit for the first quarter of 2023 was... Read More
SAN CLEMENTE, Calif., April 24, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its first quarter 2023 earnings release and conference call. The Company will release its first quarter 2023 results on Monday, May 8 th , 2023 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference... Read More
SAN CLEMENTE, Calif., March 09, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will participate in a virtual fireside chat at the KeyBanc Life Sciences & MedTech Investor Forum at 7:30 a.m. PT (10:30 a.m. ET) on Wednesday, March 22, 2023. Company management will also be participating in... Read More
SAN CLEMENTE, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarter ended December 31, 2022. Fourth Quarter 2022 Results Fourth quarter 2022 revenue was $578.0 million, compared to $340.5 million in the same period last year. GAAP gross profit for the fourth quarter of 2022... Read More
SAN CLEMENTE, Calif., Feb. 21, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the Raymond James 44 th Annual Institutional Investors Conference being held in Orlando, Florida, March 5-8, 2023. ICU Medical’s presentation will be on Monday, March 6, 2023 at 8:00 a.m. PT (11:00... Read More
SAN CLEMENTE, Calif., Feb. 13, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its fourth quarter 2022 earnings release and conference call. The Company will release its fourth quarter 2022 results on Monday, February 27 th , 2023 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a... Read More
KLAS Research recognizes Plum 360 as Best in KLAS for the sixth straight year, highlighting ICU Medical's commitment to providing constantly high levels of service and value to its customers SAN CLEMENTE, Calif. , Feb. 8, 2023 /PRNewswire/ -- ICU Medical Inc. , a worldwide leader in the development, manufacture, and sale of innovative medical devices, today announced its Plum 360 smart infusion system is the first to be... Read More
SAN CLEMENTE, Calif., Dec. 19, 2022 (GLOBE NEWSWIRE) -- ICU Medical, (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the J.P. Morgan 41 st Annual Healthcare Conference, being held in San Francisco, CA, January 9-12, 2023. ICU Medical’s presentation will be on Wednesday, January 11, 2023 at 1:30 p.m. PST (4:30 p.m. EST).... Read More
Surmodics

COPYRIGHT ©2023 HEALTH STOCKS HUB